Conference: Virtual ISPOR 2021
Did you miss PRECISIONadvisors at Virtual ISPOR 2021? Check out all of our presentations and download our posters from the conference here.
Are YOU ready to make the most of China’s evolving pharmaceutical reimbursement landscape?
China, the second largest pharmaceutical market in the world (valued at more than $150 billion), is experiencing a paradigm shift characterized by a booming economy, a growing middle class, and an increasingly aged population with rising disease rates. By reviewing recent changes to the Chinese pricing and market access landscape, PRECISIONadvisors’ Andrea Ong and Laura Montani discuss how manufacturers can capitalize on this booming market.
David Carr: Readout and Analysis of Two World Orphan Drug Congress 2021 panels
PRECISIONadvisor's Director David Carr recently attended World Orphan Drug Conference 2021, and found two panels particularly insightful: "Outlook on European market access strategies for rare diseases" and "Pricing & reimbursement for rare diseases in the United States." In case you couldn't attend, David noted the key takeaways of each presentation.
Conference Video and Download: World EPA Congress 2021
Did you miss PRECISIONadvisor's Richard Macaulay present "The Future of Innovative Reimbursement for Cell & Gene Therapies" at World EPA Congress 2021?
ASGCT 2021 Conference Panel: Considerations for the Clinical Development of Cell & Gene Therapies Part 1 – Cell Therapy
Miss ASGCT 2021? Check out this cell therapy panel discussion you won't want to miss! Precision experts David Parker, Alex Grosvenor and Megan Liles, and Project Farma's John Khoury join biotech executives on the front lines of development for "Considerations for the Clinical Development of Cell & Gene Therapies." Part 1 - Cell Therapy.
On-Demand Webinar: Oncology Care in a Value-Based World
Join us for the webinar Oncology Care in a Value-Based World which will highlight the activities and needs of payers and providers as they strive to deliver high-quality oncology care in a value-based environment. In this presentation, KOLs with market access, population health, and EMR experience will share the ways in which payers and health systems are supporting a value-based approach to oncology through care initiatives, technology, and access to innovative therapies.
